How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Montironi, Rodolfo ^a   Cheng, Liang ^b   Scarpelli, Marina ^a   Mazzucchelli, Roberta ^a   Lopez Beltran, Antonio ^c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Universidad de Cordoba   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER; BLADDER TUMOR; HUMAN; HYPERPLASIA; PATHOLOGY; PRECANCER; UROTHELIUM; WORLD HEALTH ORGANIZATION;

HUMANS; HYPERPLASIA; PRECANCEROUS CONDITIONS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM; WORLD HEALTH ORGANIZATION;

EID: 79953702263     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-31     Document Type: Note

References (17)

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-1448. 10.1097/00000478-199812000-00001, 9850170.
2. Sauter G, Algaba F, Amin MB, Busch C, et al. Tumours of the urinary system. World Health Organization Classification of Tumours Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs 2004, 89-157. Lyon, IARC Press, Epstein JI, Eble JN, Sesterhenn I, Sauter G.
3. Jost SP, Gosling JA, Dixon JS. The morphology of normal human bladder urothelium. J Anat 1989, 167:103-115. 1256824, 2630525.
4. McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non neoplastic urothelium. An analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol 2001, 25:1074-1078. 10.1097/00000478-200108000-00013, 11474293.
5. Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005, 13:143-153. 10.1177/106689690501300203, 15864376.
6. Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L. Morphological diagnosis of urothelial neoplasms. J Clin Pathol 2008, 61:3-10. 10.1136/jcp.2007.049312, 17545560.
7. Hodges KB, Lopez-Beltran A, Davidson DD, Montironi R, Cheng L. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Hum Pathol 2010, 41:155-62. 10.1016/j.humpath.2009.07.002, 19762067.
8. Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L. Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology 2008, 53:621-33. 10.1111/j.1365-2559.2008.03025.x, 18422972.
9. MacLennan GT, Kirkali Z, Cheng L. Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol 2007, 51:889-897. 10.1016/j.eururo.2006.10.037, 17095142.
10. Samaratunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 2002, 60:315-319. 10.1016/S0090-4295(02)01705-3, 12137833.
11. Cheng CW, Chan LW, Chan CK, Ng CF, Cheung HY, Chan SY, Wong WS, To KF. Is surveillance necessary for inverted papilloma in the urinary bladder and urethra?. ANZ J Surg 2005, 75:213-7. 10.1111/j.1445-2197.2005.03327.x, 15839967.
12. Sung MT, Eble JN, Wang M, Tan PH, Lopez-Beltran A, Cheng L. Inverted papilloma of the urinary bladder: a molecular genetic appraisal. Mod Pathol 2006, 19:1289-94. 10.1038/modpathol.3800667, 16862073.
13. Hodges KB, Lopez-Beltran A, Maclennan GT, Montironi R, Cheng L. Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management. BJU Int 2011, 107:532-537. 10.1111/j.1464-410X.2010.09853.x, 21091975.
14. Cheng L, Montironi R, Davidson DD, Lopez-Beltran A. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 2009, 22(SUPPL 2):S70-S95. 10.1038/modpathol.2009.1, 19494855.
15. Epstein JI, Amin MB, Reuter VE. Conventional morphologic, prognostic, andpredictive factors and reporting of bladder cancer. Urinary Bladder Biopsy Interpretation 2010, Philadelphia, Lippincott Williams & Wilkins, Epstein JI.
16. Jimenez RE, Keane TE, Hardy HT, Amin MB. pT1 urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications. Adv Anat Pathol 2000, 7:13-25. 10.1097/00125480-200007010-00004, 10640198.
17. Philip AT, Amin MB, Tamboli P, Lee TJ, Hill CE, Ro JY. Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathos 2000, 24:1286-1290.